Biomarkers of disease in a case of familial lower motor neuron ALS

Fusun Baumann, Stephen E. Rose, Garth A. Nicholson, Nicole Hutchinson, Kerstin Pannek, Anthony Pettitt, Pamela A. McCombe, Robert D. Henderson

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


ALS is a fatal disease with variable clinical course. There is no single reliable marker of disease progression. Sufficient records were available to study the case history of four family members with the uncommon G93V SOD1 mutation. Distal lower motor neuron (LMN) involvement occurred in all family members with onset from 30 to 51 years of age, with progression over more than six years. Between 2002 and 2009, we used electrophysiology as a biomarker to study disease progression in one patient, assessing the number of motor units in three nerves from different limbs. The loss of motor units showed an exponential decline with different half-lives in different nerves. Diffusion tractography was compared with a control to assess upper motor neuron (UMN) involvement and showed asymmetric evidence of abnormalities of the corticospinal tracts, providing evidence of central involvement despite the absence of UMN signs.

Original languageEnglish
Pages (from-to)486-489
Number of pages4
JournalAmyotrophic Lateral Sclerosis
Issue number5
Publication statusPublished - Oct 2010
Externally publishedYes


Dive into the research topics of 'Biomarkers of disease in a case of familial lower motor neuron ALS'. Together they form a unique fingerprint.

Cite this